BLACK DIAMOND THERAPEUTICS I's ticker is and the CUSIP is 09203E955. A total of 3 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,625 | -88.0% | 2,500 | -96.0% | 0.00% | – |
| Q3 2022 | $105,000 | -24.5% | 62,100 | +9.9% | 0.00% | – |
| Q2 2022 | $139,000 | +6850.0% | 56,500 | +7971.4% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 700 | +250.0% | 0.00% | – |
| Q4 2021 | $1,000 | -90.9% | 200 | -84.6% | 0.00% | – |
| Q3 2021 | $11,000 | -52.2% | 1,300 | -31.6% | 0.00% | – |
| Q2 2021 | $23,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,300 | $11,000 | 0.00% |
| SIMPLEX TRADING, LLC | 4,100 | $50,000 | 0.00% |